TY - JOUR
T1 - HIV-1 Tat mediates degradation of RON receptor tyrosine kinase, a regulator of inflammation
AU - Kalantari, Parisa
AU - Harandi, Omid F.
AU - Hankey, Pamela A.
AU - Henderson, Andrew J.
PY - 2008/7/15
Y1 - 2008/7/15
N2 - HIV encodes several proteins, including Tat, that have been demonstrated to modulate the expression of receptors critical for innate immunity, including MHC class I, mannose receptor, and β2-microglobulin. We demonstrate that Tat targets the receptor tyrosine kinase recepteur d'origine nantais (RON), which negatively regulates inflammation and HIV transcription, for proteosome degradation. Tat decreases cell surface RON expression in HIV-infected monocytic cells, and Tat-mediated degradation of RON protein is blocked by inhibitors of proteosome activity. Tat specifically induced down-regulation of RON and not other cell surface receptors, such as the transferrin receptor, the receptor tyrosine kinase TrkA, or monocytic markers CD14 and ICAM-1. The Tat trans activation domain is required for RON degradation, and this down-regulation is dependent on the integrity of the kinase domain of RON receptor. We propose that Tat mediates degradation of RON through a ubiquitin-proteosome pathway, and suggest that by targeting signals that modulate inflammation, Tat creates a microenvironment that is optimal for HIV replication and progression of AIDS-associated diseases.
AB - HIV encodes several proteins, including Tat, that have been demonstrated to modulate the expression of receptors critical for innate immunity, including MHC class I, mannose receptor, and β2-microglobulin. We demonstrate that Tat targets the receptor tyrosine kinase recepteur d'origine nantais (RON), which negatively regulates inflammation and HIV transcription, for proteosome degradation. Tat decreases cell surface RON expression in HIV-infected monocytic cells, and Tat-mediated degradation of RON protein is blocked by inhibitors of proteosome activity. Tat specifically induced down-regulation of RON and not other cell surface receptors, such as the transferrin receptor, the receptor tyrosine kinase TrkA, or monocytic markers CD14 and ICAM-1. The Tat trans activation domain is required for RON degradation, and this down-regulation is dependent on the integrity of the kinase domain of RON receptor. We propose that Tat mediates degradation of RON through a ubiquitin-proteosome pathway, and suggest that by targeting signals that modulate inflammation, Tat creates a microenvironment that is optimal for HIV replication and progression of AIDS-associated diseases.
UR - http://www.scopus.com/inward/record.url?scp=49049117006&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=49049117006&partnerID=8YFLogxK
U2 - 10.4049/jimmunol.181.2.1548
DO - 10.4049/jimmunol.181.2.1548
M3 - Article
C2 - 18606710
AN - SCOPUS:49049117006
SN - 0022-1767
VL - 181
SP - 1548
EP - 1555
JO - Journal of Immunology
JF - Journal of Immunology
IS - 2
ER -